---
id: 030
title: Ceftazidime - Pseudomonas Specialist Cephalosporin
category: antimicrobials
subcategory: cephalosporins
tags: [ceftazidime, 3rd-generation, Pseudomonas, cystic-fibrosis, weak-gram-positive]
difficulty: medium
---

## Question

What distinguishes **ceftazidime** from other 3rd-generation cephalosporins, and why is it NOT used for empiric febrile neutropenia?

## Answer

### **Unique Spectrum:**

| Feature | Ceftazidime | Other 3rd-Gen (Ceftriaxone) |
|---------|-------------|-----------------------------|
| ***Pseudomonas* activity** | **+++** (Most potent cephalosporin) | None |
| **Gram-positive activity** | + (WEAK - worse than 1st/2nd gen) | +++ (Good MSSA, Strep) |
| **Gram-negative** | ++++ (Enterobacterales) | ++++ |
| **Streptococci** | Poor | Excellent |
| **MSSA** | Poor (avoid) | Good |

### **Key Clinical Uses:**

| Indication | Rationale |
|------------|-----------|
| ***Pseudomonas* infections** | UTI, pneumonia (NOT monotherapy for bacteremia) |
| **Cystic fibrosis exacerbations** | High-dose for *P. aeruginosa* lung infections (30-50 mg/kg) |
| **Meningitis** (*P. aeruginosa*) | CNS penetration (rare indication) |
| **Combination therapy** | + aminoglycoside or fluoroquinolone for synergy |

### **Dosing:**
- **Standard:** 1-2g IV q8h
- **Severe *Pseudomonas*/CNS:** 2g IV q8h
- **Cystic fibrosis:** 30-50 mg/kg IV q8h (up to 6-9g/day)

## Key Points

### **Why NOT for Febrile Neutropenia?**
- **Poor Gram-positive coverage** (weak vs Streptococci, MSSA)
- **IDSA recommendation:** Use cefepime instead (better dual Gram+/Gram- coverage)
- Ceftazidime monotherapy = inadequate for empiric therapy

### **When to Choose Ceftazidime Over Cefepime:**
- **Documented *Pseudomonas* infection** with ceftazidime susceptibility
- **Cystic fibrosis** exacerbation (*P. aeruginosa* colonization)
- Cefepime resistance but ceftazidime-susceptible

### **Clinical Pearls:**
- **ALWAYS combine with another agent** for *Pseudomonas* bacteremia (aminoglycoside/fluoroquinolone)
- **Do NOT use for MSSA/Streptococcal infections** - use cefazolin or ceftriaxone
- **Ceftazidime-avibactam:** New combination covers KPC carbapenemases + retains *Pseudomonas* activity

## Sources

- [Hopkins ABX Guide: Ceftazidime]
- [IDSA: Febrile Neutropenia Guidelines]
- [Wikipedia: Ceftazidime - Antibacterial Activity]

## Media

N/A
